P2Y1/P2Y12 antagonist-1

This compound, ethyl 1-[ (4-cyanobenzyl) oxy]-2- (3-cyanophenyl) -4-methyl-1H-imidazole-5-carboxylate, functions as a platelet aggregation inhibitor. It is applied in research fields such as hematology and cardiovascular pharmacology, facilitating in vitro platelet assays and in vivo studies in thrombosis models, as supported by published literature.